Journals / Turkish Journal of Gastroenterology / 2005 / Cilt: 16 - Sayı: 2

Diabetik hastalarda fekal pankreatik elastaz düzeylerinin değerlendirilmesi

Investigation of fecal pancreatic elastase-1 levels in type 2 diabetic patients

Pages
75–80
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: It was found that the exocrine function declined in 28% of type 2 diabetic patients, while there was no decrease in the control subjects.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aims: Due to the close anatomical position between the endocrine system cells and the exocrine system cells in the pancreas, some interactions could be expected in these two different types of cells.
📊
Key Findings & Data:Taking this possibility into account, we aimed to investigate the exocrine function of the pancreas in 32 diabetic patients and in 12 healthy control subjects in this study.
💡
Conclusion & Impact:Results: It was found that the exocrine function declined in 28% of type 2 diabetic patients, while there was no decrease in the control subjects.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Duyarlılık ve özgüllük · Enzim bağlı immünosorbent tayini · Pankreatik elastaz

Abstract

Background/aims: Due to the close anatomical position between the endocrine system cells and the exocrine system cells in the pancreas, some interactions could be expected in these two different types of cells. This possible exocrine dysfunction may cause difficulties in the management of blood glucose level because of secondary malabsorption which may have resulted from the exocrine dysfunction. Taking this possibility into account, we aimed to investigate the exocrine function of the pancreas in 32 diabetic patients and in 12 healthy control subjects in this study. Methods: Fecal pancreatic elastase-1 (PE1), which has a high sensitivity and specificity, was measured in serum samples by ELISA specifically for this purpose. Results: It was found that the exocrine function declined in 28% of type 2 diabetic patients, while there was no decrease in the control subjects. However, there were no significant correlations between pancreatic elastase levels and the duration of diabetes, glycemic control, or consumption of alcohol. Conclusions: These findings suggest that evaluation of the exocrine function in diabetic patients might be useful for better management of diabetic patients.

Özet

Amaç: Pankreasta endokrin sistem hücreleri ile egzokrin sistem hücreleri arasındaki yakın komşuluk ilişkisi dolayısıyla, bu iki hücre tipi arasında bazı etkileşimlerin olması olasıdır. Bu olası egzokrin fonksiyon bozukluğu malabsorbsiyonla sonuçlanarak kan şekerinin düzenlenmesinde zorluklara neden olabilir. Tüm bunlar dikkate alınarak, çalışmamızda diabet tanısı kesinleşmiş ve insulin kullanan 32 tip 2 diabetli hastadan ve 12 sağlıklı bireyden oluşan kontrol grubunda, egzokrin pankreas fonksiyonları değerlendirmek üzere pankreatik elastaz ölçümünün tip 2 diabetik hastalarda klinik faydasını araştı rmayı amaçladık. Yöntem: Egzokrin fonksiyonu değerlendirebilmek için yüksek sensitivite ve spesifiteye sahip fekal pankreatik elastaz-1 testi kullanıldı. Alınan serumlar ELISA metoduyla analiz edildi. Bunlara ilave olarak PE1’in cins, diabet süresi, glukoz düzeyleri, vücut kitle indeksi gibi karakteristikleri ile olan ilişkilerini inceledik. Bulgular: Tip 2 diabetes mellituslu hastaların 9’unda (% 28) azalmış egzokrin fonksiyon saptanırken de kontrol grubunda fekal elastaz düzeylerinde herhangi bir azalma saptanmadı. Fakat, tip 2 diabetes mellituslu hastalardaki elastaz düzeylerinin kontrol grubuyla karşı- laştırıldığında anlamlı olarak azalmış olduğu gözlense de, elastaz düzeylerindeki azalmanın diabet süresi, glisemik kontrol ve alkol tüketimi ile ilişkisini gösterebilecek anlamlı bir korelasyona rastlanmadı. Sonuç: Elde edilen bulgular diabetes mellitus gibi sık görülen bir hastalığın uzun vadeli tedavisinde egzokrin yetmezliğin değerlendirilmesinin yararlı olduğunu düşündürmektedir.

🔖

Cite This Article

YILMAZTEPE, A., ULUKAYA, E., ERSOY, C., YILMAZ, M., TOKULLUGİL, H. A. (2005). Diabetik hastalarda fekal pankreatik elastaz düzeylerinin değerlendirilmesi. Turkish Journal of Gastroenterology, Cilt: 16 - Sayı: 2, 75–80. https://ajindex.com/articles/411179

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Kloppel G, Bommer G, Commandeur G, et al. The endocrine pancreas in chronic pancreatitis. Immunocytochemical and ultrastructural studies (Abstract). Virchows Arch A Pathol Anat Histol 1978; 377: 157-74
  2. Gatling W, Mullee M, Hill R. General characteristics of community based diabetic population. Pract Diabetes 1988; 5: 104-7
  3. Lankisch PG, Manthey G, Otto J, et al. Exocrine pancreatic function in insulin–dependent diabetes mellitus. Digestion 1982; 25: 210-6
  4. Gilbeau J, Poncelet V, Libon E, et al. The density, contour and thickness of pancreas in diabetics. AJR Am J Roentgenol 1992; 159: 527-31
  5. Foulis AK, Frier BM. Pancreatic endocrine-exocrine function in diabetes: an old alliance disturbed. Diabetic Med 1984; 1: 263-6
  6. Fonseca V, Berger LA, Beckett AG, et al. Size of the pancreas in diabetes mellitus: a study based on ultrasound. BMJ 1985; 291:1240-1
  7. DiMagno EP, Go VLM, Summerskill WHJ. Relations between pancreatic enzyme outputs and malabsorption in severe pancreatic insufficiency. N Engl J Med 1973; 288: 813-5
  8. Ammann RW, Akovbiantz A, Hacki W, et al. Diagnostic value of the fecal chymotrypsin test in pancreatic insufficiency, particularly chronic pancreatitis: correlation with the pancreozymin-secretion test, fecal fat excretion and clinical diagnosis. Digestion 1981; 2: 281-9
  9. Lami F, Callegari C, Miglioli M, et al. A single specimen fecal chymoptrypsin-test in the diagnosis of pancreatic insufficiency: correlation with the secretin-cholecystokinin and NBT-PABA tests. Am J Gastroenterol 1984; 79: 697-700
  10. Durr HK, Otte M, Forell MM, et al. Fecal chymotrypsin: a study on its diagnostic value by comparison with secretincholecystokinin test (Abstract). Digestion 1978; 17: 404-9
  11. Sale JK, Goldberg D, Thjodleifsson B, et al. Trypsin and chymotrypsin in duodenal aspirate and feces in response to secretin cholecystokinin-pancreozymin. Gut 1974; 15: 132-8
  12. Sziegoleit A. A novel proteinase from human pancreas. Biochem J 1984; 219: 735-42
  13. Sziegoleit A, Linder D. Studies on the sterol-binding capacity of human pancreatic elastase. Gastroenterology 1991; 100: 768-74
  14. Sziegoleit A, Krause E, Kleur HU, et al. Elastase and chymotrypsin B in pancreatic juice and feces. Clin Biochem 1989; 22: 85-9
  15. Muench R, Ammann R. Fecal immunoreactive lipase: a new tubeless pancreatic function test. Scand J Gastroenterol 1992; 27: 289-94
  16. Dominquez-Munoz JE, Hieronymus C, Sauerbruch T, et al. Fecal elastase test: evaluation